Lynozyfic
Product Images NDC 61755-054

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lynozyfic (NDC 61755-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mg / 2.5 mL Vial Carton)

Packaging label for LYNOZYFIC (linvoseltamab-gcpt) Injection, 5 mg/2.5 mL (2 mg/mL) provided by Regeneron Pharmaceuticals, Inc. The label indicates it is for intravenous infusion after dilution, comes in a single-dose 2.5 mL vial, and includes dispensing instructions and a medication guide. The label features a barcode, QR code, and the Regeneron logo.*

FDA Label Image

Principal Display Panel (200 mg / 10 mL Vial Carton)

Packaging label for LYNOZYFIC (linvoseltamab-gcpt) Injection by Regeneron Pharmaceuticals, Inc. The label indicates a strength of 200 mg/10 mL (20 mg/mL) for intravenous infusion after dilution. It specifies a single-dose vial with instructions to discard unused portions and includes a note to dispense the enclosed medication guide. The label also features the Regeneron logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.